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Identification of a Functionally Relevant Adeno-Associated Virus
Rep68 Oligomeric Interface
Martino Bardelli,a Francisco Zárate-Pérez,b Leticia Agúndez,a* R. Michael Linden,a* Carlos R. Escalante,b Els Henckaertsa
Department of Infectious Diseases, King’s College London, London, United Kingdoma; Department of Physiology and Biophysics, Virginia Commonwealth University
School of Medicine, Richmond, Virginia, USAb
ABSTRACT
The life cycle of the human parvovirus adeno-associated virus (AAV) is orchestrated by four Rep proteins. The large Rep pro-
teins, Rep78 and Rep68, are remarkably multifunctional and display a range of biochemical activities, including DNA binding,
nicking, and unwinding. Functionally, Rep78 and Rep68 are involved in transcriptional regulation, DNA replication, and
genomic integration. Structurally, the Rep proteins share an AAA domain characteristic of superfamily 3 helicases, with the
large Rep proteins additionally containing an N-terminal origin-binding domain (OBD) that specifically binds and nicks DNA.
The combination of these domains, coupled with dynamic oligomerization properties, is the basis for the remarkable multifunc-
tionality displayed by Rep68 and Rep78 during the AAV life cycle. In this report, we describe an oligomeric interface formed by
Rep68 and demonstrate how disruption of this interface has drastic effects on both the oligomerization and functionality of the
Rep proteins. Our results support a role for the four-helix bundle in the helicase domain of Rep68 as a bona fide oligomerization
domain (OD).We have identified key residues in the OD that are critical for the stabilization of the Rep68-Rep68 interface; mu-
tation of these key residues disrupts the enzymatic activities of Rep68, including DNA binding and nicking, and compromises
viral DNA replication and transcriptional regulation of the viral promoters. Taken together, our data contribute to our under-
standing of the dynamic and substrate-responsive Rep78/68 oligomerization that is instrumental in the regulation of the DNA
transitions that take place during the AAV life cycle.
IMPORTANCE
The limited genome size of small viruses has driven the evolution of highly multifunctional proteins that integrate different do-
mains and enzymatic activities within a single polypeptide. The Rep68 protein from adeno-associated virus (AAV) combines a
DNA binding and endonuclease domain with a helicase-ATPase domain, which together support DNA replication, transcrip-
tional regulation, and site-specific integration. The coordination of the enzymatic activities of Rep68 remains poorly under-
stood; however, Rep68 oligomerization and Rep68-DNA interactions have been suggested to play a crucial role. We investigated
the determinants of Rep68 oligomerization and identified a hydrophobic interface necessary for Rep68 activity during the AAV
life cycle. Our results provide new insights into the molecular mechanisms underlying the regulation of the versatile Rep pro-
teins. Efficient production of AAV-based gene therapy vectors requires optimal Rep expression levels, and studies such as the one
presented here could contribute to further optimization of AAV production schemes.
Adeno-associated virus (AAV) is a human DNA virus of thefamily Parvoviridae with a unique dependence on helper vi-
ruses, such as adenovirus (Ad) or herpesvirus, for productive rep-
lication (1). In order to take advantage of host pathways and
helper virus for productive replicationwith only a limited number
of viral gene products at hand, AAV has evolved to combine mul-
tiple functions into single proteins. More specifically, a single
open reading frame (ORF) generates the nonstructural Rep pro-
teins that orchestrate the different aspects of the AAV life cycle,
including transcriptional regulation, replication, packaging, and
Rep-mediated integration. The four multidomain Rep proteins
Rep40, Rep52, Rep68, and Rep78 are generated through the use of
two promoters and alternative splicing (2, 3). All Rep isoforms
share a superfamily 3 (SF3) helicase domain (HD) that combines
ATPase and helicase activities (4, 5). The large Rep proteins,
Rep68 and Rep78, further contain an N-terminal origin-binding
domain (OBD) that specifically binds and nicks the AAV origin
(5–7). Rep78 and Rep52 have an additional zinc finger domain
that is involved in interactions with cellular proteins (8, 9). Dif-
ferences in the domain composition of the Rep isoforms confer
specific functionalities to the large and the small Rep proteins.
Rep52 and Rep40 are necessary for efficient packaging of the viral
DNA into preformed capsids but are dispensable for viral replica-
tion and integration (10). TheDNAbinding and nicking activities
of the OBD of the large Rep proteins, on the other hand, are the
basis for AAV DNA replication and integration (11, 12). More
specifically, Rep78/68 bind to the Rep binding site (RBS) in the
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inverted terminal repeats (ITRs) and execute a site- and strand-
specific nick at the nearby terminal resolution site (trs). This pro-
cess is necessary for resolution of the ITRs and completion of the
viral DNA replication cycle with the assistance of the host cell
machinery (12, 13). Similarly, theDNAbinding and endonuclease
activities are required for mediation of integration at chromo-
somal target loci that contain RBS/trs, such as the integration hot
spot AAVS1 (14–16). In addition, efficient nicking of the trs at
both the viral and cellular origins requires ATP-dependent heli-
case activity for the generation of an optimal single-stranded sub-
strate (7, 17). Finally, both the OBD and the helicase domain have
the ability to mediate the transcriptional regulation of viral and
cellular promoters by two independent mechanisms conferring
regulatory functions to both small and large Rep proteins (18–20).
Structurally, the Rep proteins belong to the SF3 of helicases, a
group ofmultifunctional viral proteins combining a characteristic
AAA motor domain, which couples ATP hydrolysis and DNA
unwinding, with an origin-binding domain to achieve rapid ori-
ginmelting (21). Othermembers of this family include the simian
virus 40 (SV40) large T antigen (LTag) and papillomavirus (PV)
E1. In contrast to the OBD of Rep, SV40 LTag and PV E1 lack
endonuclease activity. The AAV large Rep proteins are also related
to HUH endonucleases, which catalyze rolling-circle replication
(RCR) in bacteriophages and geminiviruses, as well as in bacteria
(22, 23), indicating a significant evolutionary conservation. The
large AAV Rep proteins have a complex and dynamic oligomeric
behavior that can adapt to the different DNA substrates present
during the AAV life cycle, varying from the RBS-containing dou-
ble-stranded DNA encountered during initial origin binding to
the single-stranded DNA encountered after origin melting (24,
25). In contrast to the AAA domains of SV40 LTag and PV E1,
which readily formhexameric rings (26, 27), Rep40 andRep52 are
monomeric, due to the absence of a complete oligomerization
domain (OD) at the N terminus of the SF3 helicase domain (28).
Mutation of the corresponding OD in SV40 LTag and PV E1 has
been shown to prevent their oligomerization and to disrupt the
replication of SV40 and PV, respectively (29, 30). Intriguingly, a
similar OD was also found in oligomeric HUH endonucleases,
such as RepB from the pMV158 streptococcal RCR plasmid, de-
spite the absence of a helicase domain (31). In the large Rep pro-
teins, the linker connecting the OBD and the helicase domain
provides the residues necessary to complete the OD and plays a
crucial role in the oligomerization of the large Rep proteins (28,
32). Thus, the OBD, linker, and helicase domain effectively inter-
act cooperatively to promote oligomerization.
While recent findings have significantly contributed to the un-
derstanding of the determinants of Rep oligomerization (25, 28,
32), its relevance in the context of the AAV life cycle remains to be
elucidated. In order to gain an understanding of how oligomer-
ization contributes to themultiple enzymatic functions of the Rep
proteins, we took advantage of our previous findings, which
showed that the linker domain and, in particular, the N-terminal
linker residue Y224 are essential for Rep oligomerization (28).
This residue was found in a position equivalent to that of the
residues in SV40 LTag and PV E1 known to be crucial for the
formation andmaintenance of the oligomeric interface (28). Here
we describe an oligomeric interface for Rep, identified in a dimeric
complex modeled using the Rep40 structure with a predicted ex-
tended N-terminal -helix to complete the OD (33). This model
highlights a potential role for Y224 and I251 in the formation of
the oligomeric interface; site-directedmutagenesis confirmed that
oligomerization is indeed hampered when Y224 and I251 are al-
tered. Moreover, we could demonstrate that mutations that lead
to a disruption of the interface result in defects in DNA binding
and trs nicking and alter the expression levels of the viral proteins,
with severe consequences on viral DNA replication and produc-
tion of infectious virus.
MATERIALS AND METHODS
Protein production and purification. All mutations were generated in
the pHisRep68/15b plasmid, which contains the AAV serotype 2 (AAV2)
Rep68 ORF subcloned in the vector pET-15b (Novagen), using a
QuikChange mutagenesis kit (Agilent Technologies Inc.). All proteins
were expressed inEscherichia coliBL21(DE3) cells (Novagen) and purified
as described previously (28). In brief, cell pellets were lysed in Ni-buffer A
(20 mM Tris-HCl [pH 7.9 at 4°C], 500 mMNaCl, 5 mM imidazole, 10%
glycerol, 0.2% CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-1-
propanesulfonate}, 1 mM TCEP [Tris(2-carboxyethyl)phosphine hydro-
chloride]) and purified using an Ni column. The hexahistidine tag was
removed using PreScission protease, and Rep68 was further purified by
gel filtration chromatography using aHiLoad Superdex 200 16/60 column
(GEHealthcare) and size exclusion buffer (25mMTris-HCl [pH 8.0], 200
mM NaCl, 2 mM TCEP). Rep68 wild-type (WT) and mutant proteins
were concentrated to 10 mg/ml, flash-frozen in liquid N2, and kept at
80°C.
Sedimentation velocity experiments. Analytical ultracentrifugation
experiments were carried out using a Beckman Optima XL-I analytical
ultracentrifuge (Beckman Coulter Inc.) equipped with both four- and
eight-position rotors. Protein samples (420 l; final concentration, 10
M) were loaded in the cells, and in all cases, buffer containing 25 mM
Tris-HCl, pH 8.0, and 200 mMNaCl was used. Samples were centrifuged
in 2-sector carbon-filled Epon centerpieces at 25,000 rpm at 20°C. At least
200 scans were collected at 5-min intervals at 25,000 rpm. Sedimentation
velocity-concentration profiles were collected using both UV absorption
(280 nm) and Rayleigh interference scanning optics. Results were ana-
lyzed using the SEDFIT program (34, 35).
AAV infectious particle assay. 293T cells were triple transfected with
an AAV2 inverted terminal repeat (ITR)-containing plasmid carrying a
CAG-controlled green fluorescent protein (GFP) gene (pTRUF11), a
helper plasmid expressing AAV2 Rep (WT or mutants) and Cap, and a
third construct containing the adenovirus helper functions (HGTI plas-
mid) (36, 37). The mutations in Rep were confirmed in all plasmids by
sequencing (Eurofins). After 72 h, the supernatant was harvested and
spun to clear the cellular debris, and increasing volumes of superna-
tant were used to transduce HeLa cells. The percentage of GFP-positive
HeLa cells was determined at 48 h postransduction by flow cytometry
(FACSCanto; BD Biosciences).
qPCR-based replication assay. 293T cells were transfected with poly-
ethylenimine (Polysciences, Inc.) and the infectious AAV plasmid pAV2
(38) or its mutant versions and superinfected 4 h later with adenovirus
serotype 5 (Ad5) at a multiplicity of infection (MOI) of 5. After 72 h, cells
were harvested in phosphate-buffered saline (PBS) and pelleted, and the
pellet was divided into 4. One-fourth was used for RNA extraction, one-
fourthwas used for protein extraction, one-fourthwas used for total DNA
extraction, and the last quarter was used for Hirt extraction of low-mo-
lecular-weight DNA.
Total DNA was extracted using a Qiagen DNeasy blood and tissue
DNA extraction kit. Viral DNAwas quantified by real-time PCR using the
SYBR green JumpStart Taq ReadyMix for quantitative PCR (qPCR;
Sigma-Aldrich) and an ABI Prism system (Applied Biosystems). Cap
primers (forward [fw] primer, TTCTCAGATGCTGCGTACCGGAAA;
reverse [rv] primer, TCTGCCATTGAGGTGGTACTTGGT) and a pAV2-
based standard curve were used for absolute quantification; the signal was
normalized to that of cyclophilin (fw primer, TGCTGGACCCAACACA
AATG; rv primer, TGCCATCCAACCACTCAGTCT).
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Analysis of replicative intermediates. 293T cells were treated as de-
scribed above for the qPCR-based replication assay. Low-molecular-
weight DNA was extracted using a modified version of the Hirt extract
procedure (39). Briefly, cells were lysed in Hirt lysis buffer (0.6% SDS, 10
mM Tris, pH 7.5, 10 mM EDTA) and treated with proteinase K (Thermo
Fisher) to digest proteins. The high-molecular-weight DNA was precipi-
tated anddiscarded. The low-molecular-weightDNAwas then purified by
phenol extraction, followed by sodium acetate and isopropanol precipi-
tation. The precipitatedDNAwas washed and resuspended inDNase-free
water. The extracts were digested with the restriction enzyme DpnI (New
England BioLabs) to digest input DNA. Samples were run on a 0.8%
agarose gel at 30 V overnight and transferred to a nitrocellulose mem-
brane by the Southern blotting method. The membranes were hybridized
overnight in 0.75 nylon wash buffer (40.6 g Na2HPO4, 18.65 g EDTA, and
500 g SDS in 3.58 liters of double-distilled H2O, pH 7.2) at 65°C with a
radiolabeled Rep probe (fw primer, 5=-AACTGGACCAATGAGAACTTT
CC-3=; rv primer, 5=-A AAAAGTCTTTGACTTCCTGCTT-3=) or an am-
picillin probe (fw primer, 5=-AATCAGTGAGGCACCTATCTCAGC-3=;
rv primer, 5=-AACTCGGTCGCCGCATACACTATT-3=) to control for
DpnI digestion. The probes were labeled with a Prime-It RmT random
primer labeling kit from Stratagene and [32P]dCTP (PerkinElmer). The
membranes were exposed to a PhosphorImager screen overnight. Images
were acquired using a Typhoon PhosphorImager (Molecular Dynamics)
and analyzed with ImageQuant TL software (GE Healthcare Life Sci-
ences).
Fluorescence anisotropy DNA binding assay. Binding assays were
performed using a fluorescein-labeled 41-mer containing AAVS1 or p5
RBS sequences. The sequences used were 5=-TGGCGGCGGTTGGGGCT
CGGCGCTCGCTCGCTCGCTGGGCG-3= (AAVS1) and 5=-ACCGGGC
AAAATGGAGACCCTGCGTGCTCACTCGGGCTTAA-3= (p5), where
theAAVS1 and p5 sequences are in italics (40, 41). Rep68WT andmutant
proteins at concentrations ranging from 5 nM to 3 M were mixed with
DNA (5 nM) in a final volume of 300l using the following buffer: 25mM
HEPES (pH7.0), 100mMNaCl, 1mMTCEP. Fluorescence readings were
taken on a PC1 fluorimeter (ISS, Inc.) with excitation and emission filters
at 490 and 520 nm, respectively. The tubeswere equilibrated at 20°C for 20
min beforemeasurement. Each anisotropy point is the average of 10mea-
surements. Anisotropy is calculated as the ratio of the difference between
the vertical and horizontal emission intensities to the total normalized
intensity. The fraction of DNAbound (B) was calculated using the follow-
ing equation: B  ([A]x  [A]DNA)/([A]final – [A]DNA), where [A]x rep-
resents the anisotropymeasured at protein concentration x, [A]DNA is the
anisotropy of free fluorescent DNA, and [A]final is the anisotropy at satu-
ration. The data were fit to a single binding site model by use of the Hill
coefficient and the program Origin (Origin Labs). Each experiment was
done in triplicate.
Helicase assay. The substrate used in the helicase assay is a heterodu-
plexDNAconsisting of an 18-bpduplex regionwith a 10-nucleotide 3= tail
at the bottom strand, referred to as 18ADT10A. The top strand (trap
DNA) is labeled at the 5= end with fluorescein and is released upon
unwinding. The sequences used were 5=-F-CATATGGAGCAGAACA
GA-3= for the trap DNA and 5=-AGACAAGACGAGGTATACA
AAAAAAAAA-3= for the complementary strand.
All reactions were performed in a buffer containing 25mMHEPES, 50
mMNaCl (pH 7.0) at a total volume of 50 l. Protein (1 mM) was mixed
with 0.5mMdouble-stranded fluorescein-labeledDNA (18ADT10A) and
2.5 M single-stranded DNA (18-nucleotide sense DNA), and the mix-
turewas then added to themix of buffer described above containing 5mM
ATP and 5 mMMgCl2. The reaction mixture was incubated at 25°C for 1
h. EDTA was used at a final concentration of 20 M to stop the reaction.
Aliquots of 10 l were loaded in a 12% bisacrylamide gel (30%) (19:1)
using 6 loading dye (0.25% xylene cyanol FF, 30% glycerol). For the
densitometry and analysis of the bands, a Gel Doc EZ imager was used,
together with the automatic lane and band detection tool. Lane back-
ground subtraction, white illumination, and an activation time of 300 s
were used for the analysis.
scDNA nicking assay. Supercoiled DNA (scDNA) nicking activity for
Rep68 was assayed as described previously (14). Briefly, assays were per-
formed in 30-l reaction mixtures containing 30 mMHEPES-KOH (pH
7.5), 7 mM MgCl2, 0.5 mM dithiothreitol, 4 mM ATP, 40 mM creatine
phosphate (Sigma), and 1 g creatine phosphokinase (Sigma) in 15 mM
(final concentration) NaCl. One hundred nanograms of supercoiled plas-
mid DNA and 200 ng of purified His-Rep68 (or mutants) were added to
the reaction mixtures. All samples were incubated for 1 h at 37°C; the
reaction was terminated by adding 10 l of stop reaction mixture (pro-
teinase K [1.2 g/l], 0.5% SDS, 30 mM EDTA, pH 7.5) and incubating
for 1 h at 37°C. Samples were resolved in a 1% agarose gel (1 Tris-
acetate-EDTA [TAE]), which was subsequently stained with ethidium
bromide (0.3 g/ml) in 1 TAE. The plasmids carrying scDNA used in
this assay were pRVK (which containsAAVS1 fromnucleotides 1 to 3536)
and a mutated version containing a mutant trs sequence (42).
Western blotting. Proteins were extracted from cells transfected and
infected as described above for the replication assays. Cells were lysed in
radioimmunoprecipitation assay buffer, and the cleared lysate was run on
a 12% acrylamide gel. The proteins were transferred onto a nitrocellulose
membrane (GEHealthcare) and immunoblotted using anti-Rep antibody
(1/100 dilution; clone 303.9; Progen), anti-Cap antibody (1/500 dilution;
clone B1; American Research Products), and anti-HSP90 antibody (poly-
clonal, 1/5,000 dilution; Santa Cruz). All antibodies were incubated in
blocking buffer (5%nonfat driedmilk in PBS containing 0.1%Tween 20).
Images were acquired and analyzed using an ImageQuant apparatus (GE
Healthcare).
Real-time quantitative RT-PCR. 293T cells were transfected and in-
fected as described above for the replication assays. Total RNA was ex-
tracted using anRNeasy kit (Qiagen) afterDNase I (Qiagen) treatment for
15 min at 37°C. Reverse transcription (RT) was performed using a high-
capacity reverse transcription kit (Applied Biosystems). cDNA was quan-
tified by real-time qPCR on an ABI Prism system (Applied Biosystems)
using the TaqMan Universal PCR master mix (Life Technologies) and
custom-designed primer-probe mixes (Eurofins). The following primers
were used: p5 fw (5=-AACAAGGTGGTGGATGAGT-3=), p5 rv (5=-CGT
TTACGCTCCGTGAGATT-3=), p19 fw (5=-TCACCAAGCAGGAAGTC
AAAG-3=), p19 rv (5=-CCCGTTTGGGCTCACTTATATC-3=), p40 fw
(5=-GGAAGCAAGGCTCAGAGAAA-3=), and p40 rv (5=-CCTCTCTGG
AGGTTGGTAGATA-3=). The following probes were used: p5 (5=-FAM-
ACGTGGTTGAGGTGGAGCATGAAT-TAM-3=), p19 (5=-FAM-ACGTG-
GTTGAGGTGGAGCATGAA-TAM-3=), and p40 (5=-FAM-AGGAAATCA
GGACAACCAATCCCGT-TAM-3=), where FAM is 6-carboxyfluorescein
andTAMis 6-carboxytetramethylrhodamine. Relative expression levelswere
determined by the CT threshold cycle (CT) quantification method (43),
using 18S rRNA (TaqMan predeveloped assay reagents, human 18S rRNA;
Applied Biosystems) as a housekeeping reference gene.
RESULTS
Y224 forms hydrophobic interactions necessary for Rep68
oligomerization. Previous studies using Rep68* (or Rep* for
short), a C151S Rep mutant that is functionally equivalent to WT
Rep68 but that prevents protein aggregation in solution (25),
showed that Rep68 exists as a mixture of oligomers in solution.
More specifically, two major populations have been observed by
sedimentation velocity experiments, including amonomer-dimer
peak that sediments at	3S and oligomeric rings that sediment at
13S (25). We also showed that replacement of the tyrosine posi-
tioned at the C-terminal end of the linker in Rep68 by the smaller
residue alanine disrupts its oligomerization; this is presumably
because of a reduction in the surface-exposed area (Fig. 1A) (28).
To further confirm this hypothesis, we mutated the tyrosine to
phenylalanine (Phe), proline (Pro), or aspartic acid (Asp) and
Bardelli et al.
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performed sedimentation velocity experiments to study how these
mutations affect oligomerization. Figure 1B shows that replace-
ment of the tyrosine with the small-side-chain amino acids Pro
andAsp had a drastic effect on the sedimentation profile of Rep68.
The 13S peak disappeared, and the most prominent population
present in solution had a sedimentation coefficient of about 5S,
suggestive of low-molecular-weight oligomers (Fig. 1B). Exchang-
ing the tyrosine with the bulky aromatic Phe resulted in the ap-
pearance of two peaks, one with a sedimentation coefficient of 5S,
similar to what we observed for the other mutants, and a second
peak of about 12S, which was indicative of the formation of larger
oligomers. This 12S population, however, had a sedimentation
coefficient smaller than what we observed with Rep68, potentially
suggesting that the Y224F mutant forms different oligomeric spe-
cies. Figure 1C shows the quantification of the 13S population that
was formed in the presence of the different mutations. Taken to-
gether, these results demonstrate that the bulky aromatic charac-
ter of the Y224 residue is pivotal for Rep68 oligomerization and
suggest that Y224 may participate in hydrophobic interactions as
part of an oligomeric interface.
Generationof aRep68oligomeric interfacemodel.To further
determine whether Y224 participates directly in forming an oligo-
meric interface, we modeled an oligomeric Rep dimer using the
available structure of Rep40 (PDB accession number 1S9H),
which spans residues 225 to 490 of Rep68 (33). We added the
interdomain linker residues 217 to 224 to the known Rep40 struc-
ture as an extended -helix on the basis of secondary structure
predictions (28), resulting in a Rep molecule containing residues
217 to 490 (Fig. 2A). Two of the three molecules found in the
asymmetric unit of Rep40 crystals formed a pseudodimer. The
interface formed in this dimer was similar to the oligomeric inter-
face described for other SF3 helicase structures but is not optimal
to perform catalysis (44). We used this dimer with the addition of
the linker residues as our initial interface model, and we refined it
by carrying out rigid body and side chain conformation optimi-
zation using the RosettaDock server (45, 46). Strikingly, the top 10
models generated had almost identical interfaces, as analyzed by
the program PISA (47), suggesting that our model was robust. A
representation of the Rep interfacemodel is shown in Fig. 2B. The
interface buries a total of 1,992 Å of solvent-accessible area and
includes residues from all the helices in the oligomerization do-
main (OD), the presensor 1 
-hairpin (PS1
H), the 
2
3 loop,
and residues from the Walker A andWalker B motifs (Fig. 2B). A
closer analysis revealed that the modeled linker residues partici-
pate in the interface. In particular, the conserved aromatic residue
Y224, which is at the end of the linker region, is an important
FIG 1 Role of Tyr224 in Rep68 oligomerization. (A) Schematic diagram of Rep68. The sequence of the linker is shown, and Y224 is highlighted in red. (B)
Sedimentation velocity analysis of Rep68 and different Y224 mutants. C(S), sedimentation coefficient distribution. (C) Quantification of the amount of 13S
species formed by Y224mutants. Rep68* refers to the C151Smutant, which is functionally equivalent toWTRep68 but prevents protein aggregation in solution
(25). All mutant proteins were generated in the context of Rep68*.
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FIG 2 Model of a Rep-Rep interface. (A) Ribbon representation of Rep40 extended to residue 217 as an -helix highlighted in dark blue. The Walker A and
Walker Bmotifs, PS1
H, the
2
3 loop, andOD are indicated. (B)Model of a dimeric Rep complex. The structures participating in the interface are highlighted
in red andmagenta. (C) Close-up of the interactions formed by residue Y224, including the hydrophobic interaction with I251 and the hydrogen bond with the
backbone of N254. (D) Sedimentation velocity analysis of the Rep68 I251A, Y224A-I251A (YI), and N254Amutants. All proteins were analyzed at a concentra-
tion of 1 mg/ml, as described in Materials and Methods.
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component of the oligomeric interface. In agreement with the
results shown in Fig. 1, it participates in the formation of a hydro-
phobic pocket. Among the residues from the neighboring subunit
interacting with Y224, residue I251, at a distance of 3.6 Å, takes
part in a hydrophobic interaction, whereas N254 contributes to a
hydrogen bond via its main chain carbonyl oxygen (Fig. 2C).
Mutations leading to disruption of the interface affect oligo-
merization of Rep68. Based on these observations, we generated a
Rep68* mutant with the I251A substitution (Rep68*-I251A mu-
tant) and we assessed the consequences of mutating this residue
alone or in combination with Y224 on Rep68* oligomerization.
Figure 2D shows sedimentation velocity profiles illustrating that
these mutants are mostly monomeric, thus validating the predic-
tion fromourmodel. A singleN254Amutantwas also evaluated to
confirm that the side chain of this residue does not contribute to
the oligomeric interface. As predicted, because N254 forms a hy-
drogen bond through its main chain carbonyl oxygen rather than
participates directly in the hydrophobic interface, the N254Amu-
tation showed only a mild effect on sedimentation. Furthermore,
the oligomerization defects which we observed when testing the
different Y224 mutants (Fig. 1C) could also be explained by our
modeled interface: smaller hydrophobic residues increase the sol-
vent-accessible area and destabilize the interface, while a larger
bulky residue maintains the hydrophobic pocket and possibly af-
fects only the formation of the hydrogen bond between Y224 and
N254, thus causing a milder defect. Finally, the Y224P mutation
had the strongest effect, as it probably disrupts the helical charac-
ter of this region and may affect the overall OD structure. To
investigate whether the interface that we identified is biologically
relevant and thus involved in Rep functions, we assessed how the
observed disruptions in the oligomerization profile of Rep68 af-
fect the AAV life cycle.
Rep68 oligomerization is necessary to support the AAV life
cycle. First, we verified if the aforementioned mutant Rep68 pro-
teins were stable and localized correctly to the nucleus, where they
support AAV replication. We transfected 293T cells with con-
structs expressing Rep68 or the oligomerization mutants under
the control of the cytomegalovirus promoter and assessed Rep68
protein stability and localization at 8 h posttransfection. Figure 3
demonstrates that all themutants were expressed at levels compa-
rable to those observed for WT Rep68 and translocated to the
nucleus, as expected.
Next, we assessed how disruptions in the oligomerization pro-
file of Rep68 affect the AAV life cycle. We first compared the
ability of the Rep oligomerization mutants to produce infectious
AAV particles to that of WT Rep68 and Rep68* (Fig. 4A). As a
negative control, we used the nucleoside triphosphate-binding
mutant K340H, which is deficient in ATPase and helicase activity
and does not support AAV replication (48, 49). The K340H mu-
tant, however, was still able to oligomerize and has been shown to
have a dominant negative phenotype (48–50). Recombinant
AAV2-GFP was produced in 293T cells by transfection of an ITR-
containing plasmid carrying a GFP expression cassette together
with plasmids encoding the adenovirus helper functions, AAV2
Cap, andWTRep68, Rep68*, or the interface mutants. Increasing
volumes of supernatant collected from the cultures of AAV-pro-
ducing cells were added to HeLa cells in order to assess the infec-
tivity of the produced virus. Figure 4A shows that the Y224A Rep
mutant did not support the production of infectious AAV parti-
cles, as was previously reported by us (28). The mutant with the
more conservative mutation, Y224F, which retained the potential
to partially oligomerize (Fig. 1C), was severely impaired but was
not entirely deficient in producing infectious AAV.Mutating I251
to alanine on the opposite side of the predicted interface, however,
reproduced the phenotype observed with the Y224A mutant. Not
surprisingly, the Y224A-I251A double mutant also failed to pro-
duce infectious AAV particles (Fig. 4A).
To evaluate if the failure to produce infectious particles was
due to a defect in AAVDNA replication, we determined the num-
ber of AAV genomes in the 293T producer cells by qPCR (Fig. 4B)
and studied the replicative intermediates formed duringAAV rep-
lication by Southern blotting (Fig. 4C). Both assays confirmed that
the Y224A and I251A interface mutants and the Y224A-I251A
double mutant all failed to support AAV DNA replication. Simi-
larly to what we observed in the infectious particle production
assay, the Y224F mutant supported AAV replication but did so at
levels significantly lower than those observed for RepWTor Rep*.
In addition, Fig. 4C shows that replication in the presence of the
Y224F mutant resulted in the formation of the expected replica-
tive intermediates. Background replication could be observed in
the absence of adenovirus due to the presence of E1A and E1B in
293T cells (51). Altogether, these results suggest that the oligomer-
ization interfacemutants fail to sustain AAVDNA replication and
therefore cannot support the production of infectious AAV par-
ticles.
Rep68 oligomerizationmutants are deficient in RBS-specific
DNAbinding and site- and strand-specificnickingbutmaintain
the ability to unwind unspecific DNA substrates. In order to
FIG 3 The interface mutants are stable and localize to the nucleus. (A) WT
Rep68 or Rep68 mutants were transfected in 293T cells and tested for expres-
sion levels byWestern blotting at 36 h posttransfection. Anti-HSP90 antibody
was used as loading control to ensure that a similar amount of proteinwas used
under each condition. (B) 293T cells transfected with WT Rep68 or Rep68
mutants were assessed at 48 h posttransfection by immunostaining. Merged
images showing green (Rep) and blue (DAPI [4=,6-diamidino-2-phenylin-
dole]-stained nuclei) channels are presented. Rep68*-K340H was used as a
control for nuclear localization of a well-characterized nonfunctional Rep
mutant.
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determine the cause of the replication defect of the oligomeriza-
tion-deficient mutants, we assessed various biochemical activities
in vitro. Rep has three well-characterized enzymatic functions—
RBS-specificDNAbinding, trs nicking, andATP-dependentDNA
unwinding—all of which are necessary for AAV DNA replication
and targeted genome integration. Table 1 shows the binding con-
stants of Rep68* and mutant Rep68* proteins on p5 and AAVS1
RBS-containing double-stranded DNA substrates. As expected,
both Rep68* and the control, Rep68*-K340H, efficiently bound
the specific DNA substrates (25, 52). The mutant that retained
some residual replication potential, Rep68*-Y224F, also effi-
ciently bound the p5 and AAVS1 DNA substrates. All other mu-
tants, however, lost the ability to bind both DNA substrates, with
the exception of Rep68*-I251, which maintained its ability to
FIG 4 Interface mutants do not support the AAV life cycle. (A) Increasing volumes of supernatant from 293T cells producing recombinant AAV-GFP in the
presence of WT Rep68 or Rep68 mutants were used to infect HeLa cells, and the percentage of GFP-positive (GFP) cells was determined by fluorescence-
activated cell sorting analysis. S/N, supernatant.Data are from three independent experiments and are represented as themean SEM. (B)AAVDNAreplication
under permissive (Ad) and nonpermissive (no Ad) conditions was quantified by quantitative PCR. Data from three experiments were normalized (norm) to
those obtained under permissive (Rep*Ad) conditions and are represented as the mean SEM. (C) AAV replicative intermediates generated under the same
conditions shown in panel B were visualized by Southern blotting using a Rep-specific probe. RfM, monomeric replicative form; RfD, dimeric replicative form.
TABLE 1 Binding constants of Rep68* and interface mutants on AAVS1
and p5 RBS-containing DNA
Protein
Binding constant (nM)
AAVS1-41 p5-41
Rep68* 128 203
Rep68*-K340H 123 136
Rep68*-Y224A NDa ND
Rep68*-Y224F 221 311
Rep68*-I251A 1,438 ND
Rep68*-YI ND ND
a ND, not determined due to poor binding.
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bind AAVS1-containing DNA, albeit with a 10-fold lower af-
finity than its WT counterpart. These results suggest that some
level of oligomerization is necessary for efficient RBS-specific
DNA binding by Rep68 and that the oligomeric properties of the
mutant Rep68*-Y224F are sufficient for DNA binding.
To test the ability of the Rep68mutants to unwind nonspecific
DNA, we performed a fluorescence-based helicase assay. Some-
what surprisingly, all mutants except the control K340H mutant
exhibited similar helicase activity on a heteroduplex nonspecific
DNA substrate (Fig. 5). These results suggest that under these
experimental conditions Rep68 can unwind DNA even in the ab-
sence of large complexes or, alternatively, that an oligomeric com-
plex that is stabilized by a different interface is necessary for Rep-
mediated DNA unwinding. Strand- and site-specific nicking
activity, however, appeared to diminish strongly when oligomer-
ization was disrupted in Rep68. As expected, the oligomerization-
deficient Rep mutants that failed to bind specific DNA also failed
to nick supercoiled plasmid DNA containing RBS and trs se-
quences (Fig. 6A and B). The Rep68*-Y224F mutant, despite re-
taining the ability to bind specific DNA substrates, showed only
some residual nicking activity.
Rep oligomerization is important for transcriptional regula-
tion of AAV genes. In addition to their role in AAVDNA replica-
tion, the Rep proteins coordinate the temporal regulation of tran-
scription of the viral genome during the AAV life cycle. In the
absence of helper virus, the Rep proteins participate in repressing
transcription from the three viral promoters, p5, p19, and p40,
ensuring minute levels of expression of the viral proteins. In the
presence of helper virus, i.e., during a productive infection, re-
pression of the p5 promoter is lifted by the adenoviral E1A protein
(53), and binding of Rep to the p5 promoter or the ITRs leads to
transactivation of the p19 and p40 promoters (54–56). The p5
promoter itself is also controlled by Rep, which can act both as a
repressor and as an activator through binding at the p5 or ITR
RBS, respectively (56, 57). The net result is a self-regulatory loop
that generates protein levels that are tightly controlled and are
optimal for AAV replication and packaging (58). Two mecha-
nisms of Rep-mediated repression have been identified: direct re-
pression through binding at the RBS in the p5 promoter and in-
direct repression that requires the ATPase activity of Rep (19).
In light of the dependence of transcriptional regulation on Rep
binding to the p5 promoter and ITR, we assessed whether the
oligomerization mutants also displayed defects in transcriptional
activity resulting in altered protein expression levels. As a control,
we again used the K340H ATPase mutant, which has been shown
to lead to the expression of exceedingly high Rep protein levels
under conditions permissive for AAV replication (48). Cells were
transfected with the various AAV infectious plasmids, and Rep
and Cap protein levels were determined in the presence and ab-
sence of adenovirus coinfection. In the presence of WT Rep and
the absence of adenovirus, we expected low levels of both Rep and
Cap proteins. In the presence of adenovirus, Rep protein levels
peaked at about 30 h after infection and then slowly decreased,
while Cap levels increased with viral DNA replication (56). Be-
cause we harvested the cells at 72 h posttransfection, we expected
FIG 5 Comparison of the helicase activity of the interfacemutants. The ability
of the Rep68 interface mutants to unwind a fluorescein-labeled heteroduplex
DNA substrate was assayed. Data are from three independent experiments and
are represented as the mean SEM.
FIG 6 Rep-mediated nicking of supercoiled plasmid. Supercoiled (SC) plasmid DNA containing an RBS and a trs was mixed with Rep68* or the interface
mutants. If the endonuclease activity is intact, Rep nicks and relaxes the plasmid conformation to an open circular (OC) form, which can be readily distinguished
by agarose gel electrophoresis. A trsmutant (trs-mut) plasmid that was not nicked by Rep was used as a control. Untreated DNAwas left untouched, while mock
treated plasmidwas incubated in reaction buffer for 1 h at 37°C in the absence of protein. (A)Representative agarose gel electrophoresis image. (B)Quantification
of nicking from four independent nicking experiments. Data are represented as the mean SEM.
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to see only slightly higher levels of the Rep proteins but signifi-
cantly higher Cap expression levels compared to those in cells that
were not coinfected with adenovirus. As shown in Fig. 7A, we
observed strikingly highRep protein levels in cells transfectedwith
the mutated Rep proteins, including the control K340H mutant.
Once more, we observed that the Y224F mutant showed an inter-
mediate phenotype represented by a very modest increase in Rep
protein expression levels (Fig. 7A). The Cap protein levels, on the
other hand, were found to be lower in cells expressing the mutant
proteins; we detected high Cap levels only in the presence of Rep
proteins that support the AAV life cycle, with the sole exception
being the K340H mutant (Fig. 7A). The same trend was observed
both in the presence and in the absence of adenovirus infection,
although the Cap levels were significantly lower in the absence of
helper virus. These results suggest that the oligomerization mu-
tants failed to regulate the expression levels of the AAV proteins,
most likely by failing to autoregulate the p5 promoter through
RBS binding. In view of these important differences in protein
amounts, we assessed the levels of AAV transcripts by RT-qPCR
(Fig. 6C). Because all AAV RNAs use the same polyadenylation
signal, we were not able to quantify the p19 and p40 transcripts
separately from the p5 transcripts. As expected, with all primer
sets used, which targeted p5, p5p19, and p5p19p40, we ob-
served an increase inmRNA levels in response to adenovirus coin-
fection in the presence of Rep proteins that support AAV replica-
tion. In the presence of the Y224F mutant, the response to
adenovirus was still present but was nevertheless reduced com-
pared to that in the presence of WT Rep. The oligomerization-
deficient Y224, I251, and Y224-I251 mutants, which were unable
to bind theRBS at the p5 promoter, had higher basalmRNA levels,
varying between 2- and 10-fold compared with those of the WT,
and did not respond to adenovirus infection. In the context of
adenovirus coinfection, however, the differences in mRNA levels
did not correlate with those observed for the protein levels, sug-
gesting that changes in posttranscriptional regulation also con-
tribute to the altered protein expression levels. Rep-mediated
posttranscriptional regulation has been observed before, but its
mechanism remains unknown (59). The K340H mutant, which
oligomerized but failed to support AAV replication, had consid-
erably higher basal mRNA levels than WT Rep, possibly explain-
FIG 7 Rep oligomerization is important for transcriptional regulation of AAV genes. (A) Western blot showing Rep and Cap protein levels under conditions
permissive ( adenovirus) and nonpermissive for AAV replication. The first lane in the left panel is equivalent to the third lane in the right panel. (B) The
transcription levels of AAV genes were analyzed under the same conditions shown in panel A. RNA levels were measured by RT-qPCR using three primer-probe
mixes detecting RNA from the p5 promoter only, from p5p19, and from p5p19p40. The fold change was calculated relative to the mRNA levels in the
presence of WT Rep but in the absence of adenovirus. Data are from three independent experiments and are represented as the mean SEM.
Bardelli et al.
6620 jvi.asm.org August 2016 Volume 90 Number 15Journal of Virology
 o
n
 Septem
ber 15, 2016 by KING
'S CO
LLEG
E LO
NDO
N
http://jvi.asm.org/
D
ow
nloaded from
 
ing the very high Rep and Cap protein amounts observed, and the
presence of adenovirus did not lead to a clear change in mRNA
levels. Taken together, our data support a model in which Rep
oligomerization is important for the gene regulatory function of
Rep, potentially through p5 RBS binding, which is necessary to
achieve an appropriate transcription profile.
DISCUSSION
The limited genome capacity of small viruses, such as adeno-as-
sociated virus, has driven the evolution of highly multifunctional
nonstructural proteins that combine several enzymatic functions
necessary to support the viral life cycle. In AAV, the Rep proteins
are responsible for orchestrating the entire viral life cycle, from
transcriptional regulation to replication and packaging as well as
Rep-mediated integration. The combination of several enzymatic
functions, including DNA binding, nicking, and unwinding, and
the ability to interact with a multitude of DNA substrates and
proteins allow the Rep proteins to support replication. However,
the coordination of all these functions would require a tightly
controlled system, which we envision could be provided by the
different oligomeric states that the protein assumes. During the
AAV life cycle, Rep has to catalyze reactions on different DNA
substrates, including initiation of DNA replication, recognition
and nicking of the trs, and binding to the p5 promoter, in order to
provide transcriptional regulation. It has been shown that Rep can
form different oligomeric species in vitro both in the absence of
DNA and in the presence of different DNA substrates (24, 25),
allowing an additional layer of regulation of the Rep activities
during the AAV life cycle. To fully understand the mechanism of
action of Rep on its different substrates, it is essential to identify
the oligomeric complexes formed with the different DNA mole-
cules. For example, it has been shown that Rep68 forms a double
octameric ring in the presence of single-stranded DNA as well as
on forked helicase substrates (24), whereas other reports have sug-
gested that Rep68 forms hexamers when it is bound to double-
stranded DNA (50, 60). However, the importance of these com-
plexes for the viral life cycle has not been formally addressed, and
while it is clear that Rep oligomerization is functionally relevant,
data on possible oligomerization interfaces remain scarce. Smith
and colleagues identified two regions—residues 151 to 188 and
residues 334 to 347—that, when deleted, disrupt Rep oligomer-
ization; however, they did not investigate the functional conse-
quences of these deletions (50). Intriguingly, residues 334 to 346
include the ATP binding site that has been shown to be part of the
oligomeric interface in PV E1 and SV40 LTag hexamers. A more
recent report showed that one residue, R107, which was initially
identified for its role in integration, origin binding, and nicking
and which was shown to be in direct contact with origin DNA, is
also essential for oligomerization (24, 61). Finally, we and others
have shown that the interdomain linker of Rep78/68 and, in particu-
lar, the Y224 residue are critical for Rep oligomerization (28, 32).
Building on our previous studies, we further characterized the
role of residue Y224 in Rep oligomerization. Replacement of Y224
with residues with different properties had various consequences
on Rep68* oligomerization. More specifically, replacement of
Y224 with small hydrophobic residues severely impaired oligo-
merization, while the Y224F mutant with the more conservative
mutation retained the ability to oligomerize (Fig. 1), suggesting
that Y224 participates in the formation and the stabilization of a
hydrophobic interface. This hypothesis was supported by amodel
of a dimeric Rep-Rep interaction built from the pseudodimer ob-
served in the crystal structure of Rep40 using an extended Rep40
molecule (33). In this model, a large interface that resembled the
interface formed by the PV E1 protein and included residues from
theWalker A andWalker Bmotifs, PS1
H, and the
2
3 loopwas
formed (Fig. 2). Furthermore, all the helices in the OD also par-
ticipated in the interface and formed a hydrophobic pocket, em-
phasizing the relevance of this subdomain in Rep oligomerization.
More specifically, linker residue Y224 on the extended-helix 1 of
one Rep molecule interacted with residue I251 and with the main
chain carbonyl oxygen of residue N254 on -helix 3 of the other
Rep molecule (Fig. 2C). Mutating I251 to alanine in Rep68 alone
or in combination with Y224A confirmed that this residue is im-
portant for Rep68 oligomerization. Importantly, because none of
the residues located in theOD that we identified to be participants
in the oligomeric interface are part of the catalytic sites described
within the Rep proteins, the consequences of these mutations on
the functions of the Rep proteins are likely to be due to oligomer-
ization defects. We showed that the oligomerization-deficient
Y224A, I251A, and Y224A-I251A mutants were unable to repli-
cate AAV DNA and failed to support the production of recombi-
nant AAV. Our data suggest that these defects are caused by the
loss of DNA binding and origin nicking activities by the mutant
Rep proteins and confirm that Rep oligomerization is critical for
its function in support of the AAV life cycle. We also assessed the
consequences of a more conservative mutation, Y224F, on Rep
function. This substitution maintained the bulky aromatic char-
acter of the residue, a feature that is conserved in the OD of SF3
helicases and other related proteins (28). The Rep68*-Y224F mu-
tant retained the ability to oligomerize but formed the large 13S
complexes less efficiently than Rep68* did (Fig. 1). Interestingly,
the binding of RBS-containing DNA did not appear to be com-
promised by this mutation. The Rep68*-Y224F nicking activity,
on the other hand, was severely impaired, possibly explaining the
low levels of viral replication observed (Fig. 6). In view of the
oligomeric behavior of the Y224F mutant, these results suggest
that this mutant retains the ability to form an oligomeric complex
sufficient for RBS-mediatedDNAbinding but fails to promote the
subsequent DNA nicking step. How this transition is affected,
however, is not clear. One intriguing possibility is that the initial
Rep binding to the RBS and melting of the origin promote the
recruitment of further Rep78/68 molecules and the assembly of a
second, larger Rep-DNA complex that is necessary for the nicking
reaction. Residue Y224 and, more generally, the OD could help
stabilize the formation of this complex, allowing a shift in the
interaction with the origin DNA to allow the trs nicking reaction
to take place. The Y224F mutation was previously identified in a
study by Walker et al. to be important for Rep function (62). In
contrast to our findings, however, those authors reported that the
Y224F mutant was deficient in ITR binding, endonuclease, DNA
helicase, andATPase activities. The cause of this differencemay be
due to a different experimental strategy or could possibly be ex-
plained by the presence of a maltose-binding protein (MBP) tag
(62), which may affect the already weakened oligomerization po-
tential of Rep68-Y224F.
SF3 helicases are thought to function as oligomeric complexes,
as is the case for PV E1 and SV40 LTag, which form active hexa-
meric complexes. Surprisingly, all the oligomerization-deficient
mutants described here were still able to unwind a heteroduplex
DNA substrate (Fig. 5). This suggests that interaction with and
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unwinding of 3=-tailed substrates do not require the formation of
large Rep oligomers, consistent with the helicase activity of Rep40,
or, alternatively, that the presence of heteroduplex DNA and ATP
stabilizes the formation of an oligomeric complex independently
from the oligomeric interface described here. Rep40 ismonomeric
in solution, forms transient dimers in the presence of ATP, and
retains helicase activity, albeit at a level lower than that observed
with the large Rep proteins (28, 63). Therefore, although the mu-
tants presented here do not form a complex with the AAVS1 site,
they could form transient oligomers in the presence of ATP that
are able to unwind DNA. In our previous report, we introduced
the possibility that AAV Rep proteins have evolved two distinct
helicasemodes (28): one that parallels the helicase activity of other
SF3 helicases, requires oligomeric rings, and is performed by the
large Rep proteins, and one that requires only a transient
dimerization and that is characteristic for the activity of the small
Rep isoforms. Thus, it is plausible that themutants described here
are still able to unwind DNA through the same mechanism used
by Rep52/40, but they would not support the unwinding of a
substrate that requires the helicase activity from oligomeric rings.
On the basis of the different functions of the large and small Rep
proteins in theAAV life cycle, it is tempting to suggest thatmelting
of the AAV origin, which is mediated by the large Rep proteins,
requires the formation of a stable oligomer that unwinds DNA by
a mechanism analogous to that described for other SF3 helicases,
while packaging AAV genomes into the viral capsids, which is
efficiently carried out by the small Rep proteins, may proceed
through a different helicase mode.
In addition to their role in supporting AAV DNA replication,
the enzymatic activities of the Rep proteins are also essential for
the correct transcriptional regulation of viral and cellular tran-
scripts. Because it is known that the levels of Rep proteins are
tightly regulated and not simply maximized to achieve efficient
AAV DNA replication (58, 64), we assessed whether the expres-
sion levels of AAV proteins were affected by the oligomerization
mutants. The K340HRepmutant has been shown to fail in appro-
priately regulating the expression of the AAV genes, suggesting
that the ATPase/helicase activity of Rep is involved in transcrip-
tional regulation (48). A different mechanism of transcriptional
repression that is dependent on the RBS binding activity of
Rep78/68 has also been demonstrated (20). Thus, two mecha-
nisms of repression—one that is RBS binding dependent and one
that is helicase domain dependent—exist and likely act in concert
to precisely regulate the levels of expression of the Rep proteins. In
this study, we show that regulation of AAV gene expression is
impaired in the presence of Rep oligomerization mutants that do
not bind p5 or AAVS1 DNA, indicating that at least one of two
mechanisms of repression is impaired. Our results suggest that
oligomerization of the large Rep proteins is necessary for the cor-
rect regulation of the transcription of all AAV promoters (Fig. 7).
More specifically, the oligomerization-deficient mutants fail to
induce transcription of the viral promoters upon infection with
the helper virus adenovirus, and, in addition, both large and
small Rep protein levels increase substantially in the presence of
oligomerization mutants. The presence of the Y224A mutation
creates a Kozak sequence at the p19 promoter stronger than that
achieved with WT Rep68, but this is not sufficient to explain the
differences in protein levels observed, in particular for Rep78. In
addition, the increase in Rep52 expression in the presence of the
Y224A-I251A mutations is modest compared to that observed in
the presence of Y224A alone. The differences in protein levels
observed in the presence of adenovirus, however, cannot be ex-
plained by the RNA levels alone, suggesting that there is some level
of posttranscriptional control that may also be Rep dependent. A
function for AAV Rep in this context was previously suggested in
a study by Trempe and Carter, where it was observed that the
regulation of gene expression at a transcriptional level alone was
not sufficient to explain differences in protein levels (59).Our data
also support a role for an oligomeric complex of Rep in regulating
protein levels posttranscriptionally. Understanding the mecha-
nism behind this potential uncharacterized function of AAV Rep
proteins may reveal a new layer of complexity in the role that the
Rep proteins play in coordinating the AAV life cycle.
In conclusion, our study identifies and describes an essential
Rep-Rep protein interface that is involved in the formation of Rep
complexes and demonstrates its functional relevance throughout
the AAV life cycle. Our study focuses on residues that are part of
the -helical bundle located upstream of the helicase domain and
strengthens the suggestion that this subdomain of Rep plays a role
as a bona fide oligomerization domain. The identification of the
oligomeric interfaces of AAV Rep like the one described here and
further structural and functional characterization of Rep oligo-
meric complexes, particularly in the presence of different DNA
substrates, will provide additional insights into the molecular
mechanisms of Rep-mediated transcriptional regulation andAAV
DNA replication, as well as Rep-mediated integration.
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